Initial Diagnosis and Management of Type 2 Diabetes Mellitus

Nisha Suda; Hanna J. Lee

doi:10.1007/978-3-030-84367-0_39

Initial Diagnosis and Management of Type 2 Diabetes Mellitus

Nisha Suda, Hanna J. Lee

Medicine

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Abstract

Over 34 million Americans have diabetes, of which up to 95% have type 2 diabetes mellitus (T2DM) (Centers for Disease Control (CDC). 2019 National Diabetes Fact Sheet [Internet], last reviewed May 30, 2019. Available at https://www.cdc.gov/diabetes/basics/type2.html). T2DM is an independent risk factor for cardiovascular disease and a leading cause of kidney failure, blindness, and numerous other complications. It is therefore critical for clinicians to recognize the risk factors and underlying physiology that contribute to the development of T2DM. Appropriate screening, lifestyle interventions, glycemic targets, methods of self-monitoring, and clinical management of T2DM and its sequelae (micro- and macrovascular complications) will be reviewed in this chapter.

Original language	English (US)
Title of host publication	A Case-Based Guide to Clinical Endocrinology, Third Edition
Publisher	Springer International Publishing
Pages	353-367
Number of pages	15
ISBN (Electronic)	9783030843670
ISBN (Print)	9783030843663
DOIs	https://doi.org/10.1007/978-3-030-84367-0_39
State	Published - Jan 1 2022

Keywords

Glycemic targets
Lifestyle modification
Macrovascular complications
Microvascular complications
Screening
Time in range (TIR)
Type 2 diabetes (T2DM)

ASJC Scopus subject areas

General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-030-84367-0_39

Cite this

@inbook{957a0e5ad578459c9f6f95387d6cffbe,

title = "Initial Diagnosis and Management of Type 2 Diabetes Mellitus",

abstract = "Over 34 million Americans have diabetes, of which up to 95% have type 2 diabetes mellitus (T2DM) (Centers for Disease Control (CDC). 2019 National Diabetes Fact Sheet [Internet], last reviewed May 30, 2019. Available at https://www.cdc.gov/diabetes/basics/type2.html). T2DM is an independent risk factor for cardiovascular disease and a leading cause of kidney failure, blindness, and numerous other complications. It is therefore critical for clinicians to recognize the risk factors and underlying physiology that contribute to the development of T2DM. Appropriate screening, lifestyle interventions, glycemic targets, methods of self-monitoring, and clinical management of T2DM and its sequelae (micro- and macrovascular complications) will be reviewed in this chapter.",

keywords = "Glycemic targets, Lifestyle modification, Macrovascular complications, Microvascular complications, Screening, Time in range (TIR), Type 2 diabetes (T2DM)",

author = "Nisha Suda and Lee, {Hanna J.}",

note = "Publisher Copyright: {\textcopyright} The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2008, 2015, 2022",

year = "2022",

month = jan,

day = "1",

doi = "10.1007/978-3-030-84367-0_39",

language = "English (US)",

isbn = "9783030843663",

pages = "353--367",

booktitle = "A Case-Based Guide to Clinical Endocrinology, Third Edition",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Initial Diagnosis and Management of Type 2 Diabetes Mellitus

AU - Suda, Nisha

AU - Lee, Hanna J.

N1 - Publisher Copyright: © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG 2008, 2015, 2022

PY - 2022/1/1

Y1 - 2022/1/1

N2 - Over 34 million Americans have diabetes, of which up to 95% have type 2 diabetes mellitus (T2DM) (Centers for Disease Control (CDC). 2019 National Diabetes Fact Sheet [Internet], last reviewed May 30, 2019. Available at https://www.cdc.gov/diabetes/basics/type2.html). T2DM is an independent risk factor for cardiovascular disease and a leading cause of kidney failure, blindness, and numerous other complications. It is therefore critical for clinicians to recognize the risk factors and underlying physiology that contribute to the development of T2DM. Appropriate screening, lifestyle interventions, glycemic targets, methods of self-monitoring, and clinical management of T2DM and its sequelae (micro- and macrovascular complications) will be reviewed in this chapter.

AB - Over 34 million Americans have diabetes, of which up to 95% have type 2 diabetes mellitus (T2DM) (Centers for Disease Control (CDC). 2019 National Diabetes Fact Sheet [Internet], last reviewed May 30, 2019. Available at https://www.cdc.gov/diabetes/basics/type2.html). T2DM is an independent risk factor for cardiovascular disease and a leading cause of kidney failure, blindness, and numerous other complications. It is therefore critical for clinicians to recognize the risk factors and underlying physiology that contribute to the development of T2DM. Appropriate screening, lifestyle interventions, glycemic targets, methods of self-monitoring, and clinical management of T2DM and its sequelae (micro- and macrovascular complications) will be reviewed in this chapter.

KW - Glycemic targets

KW - Lifestyle modification

KW - Macrovascular complications

KW - Microvascular complications

KW - Screening

KW - Time in range (TIR)

KW - Type 2 diabetes (T2DM)

UR - http://www.scopus.com/inward/record.url?scp=85169394737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85169394737&partnerID=8YFLogxK

U2 - 10.1007/978-3-030-84367-0_39

DO - 10.1007/978-3-030-84367-0_39

M3 - Chapter

AN - SCOPUS:85169394737

SN - 9783030843663

SP - 353

EP - 367

BT - A Case-Based Guide to Clinical Endocrinology, Third Edition

PB - Springer International Publishing

ER -

Initial Diagnosis and Management of Type 2 Diabetes Mellitus

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this